1 Min Read
Nov 15 (Reuters) - Merck & Co Inc
* Merck & Co reports 6.5 percent passive stake in Spero Therapeutics Inc as of Nov 6 - SEC Filing Source text: [bit.ly/2z57b4q] Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.